61 related articles for article (PubMed ID: 24989272)
21. Acute promyelocytic leukemia: four distinct patterns by flow cytometry immunophenotyping.
Gorczyca W
Pol J Pathol; 2012 Mar; 63(1):8-17. PubMed ID: 22535601
[TBL] [Abstract][Full Text] [Related]
22. Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
Snijder S; Mellink CH; van der Lelie H
Cancer Genet Cytogenet; 2008 Jan; 180(2):149-52. PubMed ID: 18206542
[TBL] [Abstract][Full Text] [Related]
23. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
[TBL] [Abstract][Full Text] [Related]
24. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide.
Soignet SL; Maslak P; Wang ZG; Jhanwar S; Calleja E; Dardashti LJ; Corso D; DeBlasio A; Gabrilove J; Scheinberg DA; Pandolfi PP; Warrell RP
N Engl J Med; 1998 Nov; 339(19):1341-8. PubMed ID: 9801394
[TBL] [Abstract][Full Text] [Related]
25. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
Naeem M; Harrison K; Barton K; Nand S; Alkan S
Eur J Haematol; 2006 Feb; 76(2):164-6. PubMed ID: 16405439
[TBL] [Abstract][Full Text] [Related]
26. [Combined analysis on morphology, immunology, cytogenetics and molecular biology (MICM) classification of 55 patients with acute promyelocytic leukemia].
Xiao R; Zhang R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):147-50. PubMed ID: 15157321
[TBL] [Abstract][Full Text] [Related]
27. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of RT-PCR PML-RARA transcript monitoring for extramedullary relapse of acute promyelocytic leukemia in the pleura, heart and pericardium after allogeneic SCT.
Nasilowska-Adamska B; Majewski M; Seferynska I; Szczepinski A; Tomaszewska A; Prochorec-Sobieszek M; Guz K; Torbicki A; Warzocha K; Marianska B
Ann Transplant; 2007; 12(3):33-8. PubMed ID: 18290568
[TBL] [Abstract][Full Text] [Related]
29. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
[TBL] [Abstract][Full Text] [Related]
30. Pathologic, cytogenetic and molecular assessment of acute promyelocytic leukemia patients treated with arsenic trioxide (As2O3).
Zhang T; Westervelt P; Hess JL
Mod Pathol; 2000 Sep; 13(9):954-61. PubMed ID: 11007035
[TBL] [Abstract][Full Text] [Related]
31. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
[TBL] [Abstract][Full Text] [Related]
32. [Application of Metaphase-Fluorescence in Situ Hybridization to the Diagnosis of Acute Promyelocytic Leukemia and the Detection of Minimal Residual Disease].
Zheng L; Xue Y; Li J; Guo Y; Xie X; Wang Y; Lu D
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2000 Sep; 8(3):180-184. PubMed ID: 12578678
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive review of acute promyelocytic leukemia in children.
Mantadakis E; Samonis G; Kalmanti M
Acta Haematol; 2008; 119(2):73-82. PubMed ID: 18285695
[TBL] [Abstract][Full Text] [Related]
34. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
Breccia M; Diverio D; Noguera NI; Visani G; Santoro A; Locatelli F; Damiani D; Marmont F; Vignetti M; Petti MC; Lo Coco F
Haematologica; 2004 Jan; 89(1):29-33. PubMed ID: 14754603
[TBL] [Abstract][Full Text] [Related]
35. A new cytogenetic abnormality, t(2;7)(q33;q36), in acute promyelocytic leukemia.
Owatari S; Uozumi K; Haraguchi K; Ohno N; Tokunaga M; Tokunaga M; Suzuki S; Hanada S; Arima N
Cancer Genet Cytogenet; 2007 Feb; 173(1):71-4. PubMed ID: 17284374
[TBL] [Abstract][Full Text] [Related]
36. Therapy-related myelodysplastic syndrome after eradication of acute promyelocytic leukemia: cytogenetic and molecular features.
Au WY; Lam CC; Ma ES; Man C; Wan T; Kwong YL
Hum Pathol; 2001 Jan; 32(1):126-9. PubMed ID: 11172306
[TBL] [Abstract][Full Text] [Related]
37. Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia.
Batzios C; Hayes LA; He SZ; Quach H; McQuilten ZK; Wall M; Campbell LJ
Am J Hematol; 2009 Nov; 84(11):715-9. PubMed ID: 19806661
[TBL] [Abstract][Full Text] [Related]
38. Gene rearrangements in the molecular pathogenesis of acute promyelocytic leukemia.
Kalantry S; Delva L; Gaboli M; Gandini D; Giorgio M; Hawe N; He LZ; Peruzzi D; Rivi R; Tribioli C; Wang ZG; Zhang H; Pandolfi PP
J Cell Physiol; 1997 Nov; 173(2):288-96. PubMed ID: 9365539
[TBL] [Abstract][Full Text] [Related]
39. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis.
Lin P; Hao S; Medeiros LJ; Estey EH; Pierce SA; Wang X; Glassman AB; Bueso-Ramos C; Huh YO
Am J Clin Pathol; 2004 Mar; 121(3):402-7. PubMed ID: 15023045
[TBL] [Abstract][Full Text] [Related]
40. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
Chen SJ; Chen LJ; Zhou GB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
